Global Pharmaceutical Contract Research and Manufacturing Market

Pharmaceutical Contract Research and Manufacturing Comprehensive Study by Services (Synthetic Route Design & Scouting Services, High-end Chemical Process Development, Advanced Drug Delivery Formulations Packaging, Finished Dose Formulations, Process Validation followed by Commercial Manufacturing, Others), Phase (Phase I, Phase IIa, Phase II-III, Phase IIIb-IV), Enterprise Size (Large Enterprise, Small and Medium Enterprise (SME)), Product Type (Oncology, Vaccines, Inflammation & Immunology, Cardiology, Neuroscience, Others) Players and Region - Global Market Outlook to 2026

Pharmaceutical Contract Research and Manufacturing Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Global Pharmaceutical Contract Research and Manufacturing Market Overview:
Pharmaceutical Contract Research and Manufacturing refers to a method in which the product's parent business does not actually create the product. Instead, the corporation decides to outsource all production processes to contract manufacturers with the expertise and infrastructure needed to produce the best version of that product at the lowest feasible cost. Contract research manufacturers, as the name implies, manufacture other company’s products on a contract basis. The parent firms then apply their own label and packaging to the items produced by contract manufacturers, and they have their own sales and distribution channels and networks to get the product to the end consumer. Contract research and manufacturing services (CRAMs) are one of the pharmaceutical and biotechnology industries' fastest growing sectors. Contract research organisations (CROs) and contract manufacturing organisations (CMOs) provide low-cost outsourcing services to the pharmaceutical industry (CMOs). Huge investments in R&D, followed by low productivity, are driving companies to reduce manufacturing costs by outsourcing research and manufacturing to low-cost countries. Outsourcing provides significant advantages over other matured pharmaceutical hubs.

Growth Drivers
  • Increasing Demand for Generic Medicines
  • Rising Demand for Cell and Gene Therapies

Roadblocks
  • Fluctuation in Supply Chain Due to Enforcement of Stringent Lockdown Measures

Opportunities
  • Rising Healthcare Expenditures Provides an Opportunity for CRM Market

Challenges
  • In-House Production of Pharmaceuticals Could Hamper the Market Growth


Competitive Landscape:
The demand for Pharmaceutical Contract Research and Manufacturing is increasing. The industry is segmented, but it is predicted to grow as rise healthcare expenditure and health insurance, among other factors, drive the market forward. Businesses in this sector face global competition from market leaders who control a large share of the market. Companies are differentiating their products from competition by employing environmentally friendly materials and manufacturing techniques. The Leading Players are engaging in strategic global expansion to maintain their Market Position.
Some of the key players profiled in the report are Patheon (Thermo Fisher Scientific) (United States), Boehringer Ingelheim (Germany), Labcorp (United States), IQVIA (United States), PPD, Inc. (United States), Sun Pharmaceutical Industries Ltd. (India), Medpace (United States), Syngene International Limited (India), WuXi AppTec (China), ICON plc (Ireland) and Lonza Group AG (Switzerland). Additionally, following companies can also be profiled that are part of our coverage like Charles River Laboratories (United States) and Parexel (United States). Analyst at AMA Research see United States Players to retain maximum share of Global Pharmaceutical Contract Research and Manufacturing market by 2026. Considering Market by Services, the sub-segment i.e. Synthetic Route Design & Scouting Services will boost the Pharmaceutical Contract Research and Manufacturing market. Considering Market by Phase, the sub-segment i.e. Phase I will boost the Pharmaceutical Contract Research and Manufacturing market. Considering Market by Enterprise Size, the sub-segment i.e. Large Enterprise will boost the Pharmaceutical Contract Research and Manufacturing market. Considering Market by Product Type, the sub-segment i.e. Oncology will boost the Pharmaceutical Contract Research and Manufacturing market.

Latest Market Insights:
In February 2021 Charles River Laboratories had announced the acquisition of Cognate BioServices. Cognate is a leading cell and gene therapy CDMO that provides comprehensive production solutions for cell therapies, as well as the production of plasmid DNA. The acquisition will position Charles River as a premier scientific partner for cell and gene therapy advancement, experimenting, and production, offering clients a complete solution ranging from simple research and discovery to CGMP manufacturing.

What Can be Explored with the Pharmaceutical Contract Research and Manufacturing Market Study
 Gain Market Understanding
 Identify Growth Opportunities
 Analyze and Measure the Global Pharmaceutical Contract Research and Manufacturing Market by Identifying Investment across various Industry Verticals
 Understand the Trends that will drive Future Changes in Pharmaceutical Contract Research and Manufacturing
 Understand the Competitive Scenario
- Track Right Markets
- Identify the Right Verticals

Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Pharmaceutical Contract Research and Manufacturing market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Pharmaceutical Contract Research and Manufacturing market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Venture and Capitalist, New entrants/investors, Analysts and Strategic Business Partners, Healthcare and End-use industries.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.

Report Objectives / Segmentation Covered

By Services
  • Synthetic Route Design & Scouting Services
  • High-end Chemical Process Development
  • Advanced Drug Delivery Formulations Packaging
  • Finished Dose Formulations
  • Process Validation followed by Commercial Manufacturing
  • Others

By Phase
  • Phase I
  • Phase IIa
  • Phase II-III
  • Phase IIIb-IV

By Enterprise Size
  • Large Enterprise
  • Small and Medium Enterprise (SME)

By Product Type
  • Oncology
  • Vaccines
  • Inflammation & Immunology
  • Cardiology
  • Neuroscience
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Demand for Generic Medicines
      • 3.2.2. Rising Demand for Cell and Gene Therapies
    • 3.3. Market Challenges
      • 3.3.1. In-House Production of Pharmaceuticals Could Hamper the Market Growth
    • 3.4. Market Trends
      • 3.4.1. Rapid Development of AI and Electronic Platforms in CRM
      • 3.4.2. Emergence of Blockchain in Contract Manufacturing
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Pharmaceutical Contract Research and Manufacturing, by Services, Phase, Enterprise Size, Product Type and Region (value and price ) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Pharmaceutical Contract Research and Manufacturing (Value)
      • 5.2.1. Global Pharmaceutical Contract Research and Manufacturing by: Services (Value)
        • 5.2.1.1. Synthetic Route Design & Scouting Services
        • 5.2.1.2. High-end Chemical Process Development
        • 5.2.1.3. Advanced Drug Delivery Formulations Packaging
        • 5.2.1.4. Finished Dose Formulations
        • 5.2.1.5. Process Validation followed by Commercial Manufacturing
        • 5.2.1.6. Others
      • 5.2.2. Global Pharmaceutical Contract Research and Manufacturing by: Phase (Value)
        • 5.2.2.1. Phase I
        • 5.2.2.2. Phase IIa
        • 5.2.2.3. Phase II-III
        • 5.2.2.4. Phase IIIb-IV
      • 5.2.3. Global Pharmaceutical Contract Research and Manufacturing by: Enterprise Size (Value)
        • 5.2.3.1. Large Enterprise
        • 5.2.3.2. Small and Medium Enterprise (SME)
      • 5.2.4. Global Pharmaceutical Contract Research and Manufacturing by: Product Type (Value)
        • 5.2.4.1. Oncology
        • 5.2.4.2. Vaccines
        • 5.2.4.3. Inflammation & Immunology
        • 5.2.4.4. Cardiology
        • 5.2.4.5. Neuroscience
        • 5.2.4.6. Others
      • 5.2.5. Global Pharmaceutical Contract Research and Manufacturing Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Australia
          • 5.2.5.2.6. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global Pharmaceutical Contract Research and Manufacturing (Price)
  • 6. Pharmaceutical Contract Research and Manufacturing: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Patheon (Thermo Fisher Scientific) (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Boehringer Ingelheim (Germany)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Labcorp (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. IQVIA (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. PPD, Inc. (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Sun Pharmaceutical Industries Ltd. (India)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Medpace (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Syngene International Limited (India)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. WuXi AppTec (China)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. ICON plc (Ireland)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Lonza Group AG (Switzerland)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
  • 7. Global Pharmaceutical Contract Research and Manufacturing Sale, by Services, Phase, Enterprise Size, Product Type and Region (value and price ) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Pharmaceutical Contract Research and Manufacturing (Value)
      • 7.2.1. Global Pharmaceutical Contract Research and Manufacturing by: Services (Value)
        • 7.2.1.1. Synthetic Route Design & Scouting Services
        • 7.2.1.2. High-end Chemical Process Development
        • 7.2.1.3. Advanced Drug Delivery Formulations Packaging
        • 7.2.1.4. Finished Dose Formulations
        • 7.2.1.5. Process Validation followed by Commercial Manufacturing
        • 7.2.1.6. Others
      • 7.2.2. Global Pharmaceutical Contract Research and Manufacturing by: Phase (Value)
        • 7.2.2.1. Phase I
        • 7.2.2.2. Phase IIa
        • 7.2.2.3. Phase II-III
        • 7.2.2.4. Phase IIIb-IV
      • 7.2.3. Global Pharmaceutical Contract Research and Manufacturing by: Enterprise Size (Value)
        • 7.2.3.1. Large Enterprise
        • 7.2.3.2. Small and Medium Enterprise (SME)
      • 7.2.4. Global Pharmaceutical Contract Research and Manufacturing by: Product Type (Value)
        • 7.2.4.1. Oncology
        • 7.2.4.2. Vaccines
        • 7.2.4.3. Inflammation & Immunology
        • 7.2.4.4. Cardiology
        • 7.2.4.5. Neuroscience
        • 7.2.4.6. Others
      • 7.2.5. Global Pharmaceutical Contract Research and Manufacturing Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Australia
          • 7.2.5.2.6. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global Pharmaceutical Contract Research and Manufacturing (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Pharmaceutical Contract Research and Manufacturing: by Services(USD Million)
  • Table 2. Pharmaceutical Contract Research and Manufacturing Synthetic Route Design & Scouting Services , by Region USD Million (2015-2020)
  • Table 3. Pharmaceutical Contract Research and Manufacturing High-end Chemical Process Development , by Region USD Million (2015-2020)
  • Table 4. Pharmaceutical Contract Research and Manufacturing Advanced Drug Delivery Formulations Packaging , by Region USD Million (2015-2020)
  • Table 5. Pharmaceutical Contract Research and Manufacturing Finished Dose Formulations , by Region USD Million (2015-2020)
  • Table 6. Pharmaceutical Contract Research and Manufacturing Process Validation followed by Commercial Manufacturing , by Region USD Million (2015-2020)
  • Table 7. Pharmaceutical Contract Research and Manufacturing Others , by Region USD Million (2015-2020)
  • Table 8. Pharmaceutical Contract Research and Manufacturing: by Phase(USD Million)
  • Table 9. Pharmaceutical Contract Research and Manufacturing Phase I , by Region USD Million (2015-2020)
  • Table 10. Pharmaceutical Contract Research and Manufacturing Phase IIa , by Region USD Million (2015-2020)
  • Table 11. Pharmaceutical Contract Research and Manufacturing Phase II-III , by Region USD Million (2015-2020)
  • Table 12. Pharmaceutical Contract Research and Manufacturing Phase IIIb-IV , by Region USD Million (2015-2020)
  • Table 13. Pharmaceutical Contract Research and Manufacturing: by Enterprise Size(USD Million)
  • Table 14. Pharmaceutical Contract Research and Manufacturing Large Enterprise , by Region USD Million (2015-2020)
  • Table 15. Pharmaceutical Contract Research and Manufacturing Small and Medium Enterprise (SME) , by Region USD Million (2015-2020)
  • Table 16. Pharmaceutical Contract Research and Manufacturing: by Product Type(USD Million)
  • Table 17. Pharmaceutical Contract Research and Manufacturing Oncology , by Region USD Million (2015-2020)
  • Table 18. Pharmaceutical Contract Research and Manufacturing Vaccines , by Region USD Million (2015-2020)
  • Table 19. Pharmaceutical Contract Research and Manufacturing Inflammation & Immunology , by Region USD Million (2015-2020)
  • Table 20. Pharmaceutical Contract Research and Manufacturing Cardiology , by Region USD Million (2015-2020)
  • Table 21. Pharmaceutical Contract Research and Manufacturing Neuroscience , by Region USD Million (2015-2020)
  • Table 22. Pharmaceutical Contract Research and Manufacturing Others , by Region USD Million (2015-2020)
  • Table 23. South America Pharmaceutical Contract Research and Manufacturing, by Country USD Million (2015-2020)
  • Table 24. South America Pharmaceutical Contract Research and Manufacturing, by Services USD Million (2015-2020)
  • Table 25. South America Pharmaceutical Contract Research and Manufacturing, by Phase USD Million (2015-2020)
  • Table 26. South America Pharmaceutical Contract Research and Manufacturing, by Enterprise Size USD Million (2015-2020)
  • Table 27. South America Pharmaceutical Contract Research and Manufacturing, by Product Type USD Million (2015-2020)
  • Table 28. Brazil Pharmaceutical Contract Research and Manufacturing, by Services USD Million (2015-2020)
  • Table 29. Brazil Pharmaceutical Contract Research and Manufacturing, by Phase USD Million (2015-2020)
  • Table 30. Brazil Pharmaceutical Contract Research and Manufacturing, by Enterprise Size USD Million (2015-2020)
  • Table 31. Brazil Pharmaceutical Contract Research and Manufacturing, by Product Type USD Million (2015-2020)
  • Table 32. Argentina Pharmaceutical Contract Research and Manufacturing, by Services USD Million (2015-2020)
  • Table 33. Argentina Pharmaceutical Contract Research and Manufacturing, by Phase USD Million (2015-2020)
  • Table 34. Argentina Pharmaceutical Contract Research and Manufacturing, by Enterprise Size USD Million (2015-2020)
  • Table 35. Argentina Pharmaceutical Contract Research and Manufacturing, by Product Type USD Million (2015-2020)
  • Table 36. Rest of South America Pharmaceutical Contract Research and Manufacturing, by Services USD Million (2015-2020)
  • Table 37. Rest of South America Pharmaceutical Contract Research and Manufacturing, by Phase USD Million (2015-2020)
  • Table 38. Rest of South America Pharmaceutical Contract Research and Manufacturing, by Enterprise Size USD Million (2015-2020)
  • Table 39. Rest of South America Pharmaceutical Contract Research and Manufacturing, by Product Type USD Million (2015-2020)
  • Table 40. Asia Pacific Pharmaceutical Contract Research and Manufacturing, by Country USD Million (2015-2020)
  • Table 41. Asia Pacific Pharmaceutical Contract Research and Manufacturing, by Services USD Million (2015-2020)
  • Table 42. Asia Pacific Pharmaceutical Contract Research and Manufacturing, by Phase USD Million (2015-2020)
  • Table 43. Asia Pacific Pharmaceutical Contract Research and Manufacturing, by Enterprise Size USD Million (2015-2020)
  • Table 44. Asia Pacific Pharmaceutical Contract Research and Manufacturing, by Product Type USD Million (2015-2020)
  • Table 45. China Pharmaceutical Contract Research and Manufacturing, by Services USD Million (2015-2020)
  • Table 46. China Pharmaceutical Contract Research and Manufacturing, by Phase USD Million (2015-2020)
  • Table 47. China Pharmaceutical Contract Research and Manufacturing, by Enterprise Size USD Million (2015-2020)
  • Table 48. China Pharmaceutical Contract Research and Manufacturing, by Product Type USD Million (2015-2020)
  • Table 49. Japan Pharmaceutical Contract Research and Manufacturing, by Services USD Million (2015-2020)
  • Table 50. Japan Pharmaceutical Contract Research and Manufacturing, by Phase USD Million (2015-2020)
  • Table 51. Japan Pharmaceutical Contract Research and Manufacturing, by Enterprise Size USD Million (2015-2020)
  • Table 52. Japan Pharmaceutical Contract Research and Manufacturing, by Product Type USD Million (2015-2020)
  • Table 53. India Pharmaceutical Contract Research and Manufacturing, by Services USD Million (2015-2020)
  • Table 54. India Pharmaceutical Contract Research and Manufacturing, by Phase USD Million (2015-2020)
  • Table 55. India Pharmaceutical Contract Research and Manufacturing, by Enterprise Size USD Million (2015-2020)
  • Table 56. India Pharmaceutical Contract Research and Manufacturing, by Product Type USD Million (2015-2020)
  • Table 57. South Korea Pharmaceutical Contract Research and Manufacturing, by Services USD Million (2015-2020)
  • Table 58. South Korea Pharmaceutical Contract Research and Manufacturing, by Phase USD Million (2015-2020)
  • Table 59. South Korea Pharmaceutical Contract Research and Manufacturing, by Enterprise Size USD Million (2015-2020)
  • Table 60. South Korea Pharmaceutical Contract Research and Manufacturing, by Product Type USD Million (2015-2020)
  • Table 61. Australia Pharmaceutical Contract Research and Manufacturing, by Services USD Million (2015-2020)
  • Table 62. Australia Pharmaceutical Contract Research and Manufacturing, by Phase USD Million (2015-2020)
  • Table 63. Australia Pharmaceutical Contract Research and Manufacturing, by Enterprise Size USD Million (2015-2020)
  • Table 64. Australia Pharmaceutical Contract Research and Manufacturing, by Product Type USD Million (2015-2020)
  • Table 65. Rest of Asia-Pacific Pharmaceutical Contract Research and Manufacturing, by Services USD Million (2015-2020)
  • Table 66. Rest of Asia-Pacific Pharmaceutical Contract Research and Manufacturing, by Phase USD Million (2015-2020)
  • Table 67. Rest of Asia-Pacific Pharmaceutical Contract Research and Manufacturing, by Enterprise Size USD Million (2015-2020)
  • Table 68. Rest of Asia-Pacific Pharmaceutical Contract Research and Manufacturing, by Product Type USD Million (2015-2020)
  • Table 69. Europe Pharmaceutical Contract Research and Manufacturing, by Country USD Million (2015-2020)
  • Table 70. Europe Pharmaceutical Contract Research and Manufacturing, by Services USD Million (2015-2020)
  • Table 71. Europe Pharmaceutical Contract Research and Manufacturing, by Phase USD Million (2015-2020)
  • Table 72. Europe Pharmaceutical Contract Research and Manufacturing, by Enterprise Size USD Million (2015-2020)
  • Table 73. Europe Pharmaceutical Contract Research and Manufacturing, by Product Type USD Million (2015-2020)
  • Table 74. Germany Pharmaceutical Contract Research and Manufacturing, by Services USD Million (2015-2020)
  • Table 75. Germany Pharmaceutical Contract Research and Manufacturing, by Phase USD Million (2015-2020)
  • Table 76. Germany Pharmaceutical Contract Research and Manufacturing, by Enterprise Size USD Million (2015-2020)
  • Table 77. Germany Pharmaceutical Contract Research and Manufacturing, by Product Type USD Million (2015-2020)
  • Table 78. France Pharmaceutical Contract Research and Manufacturing, by Services USD Million (2015-2020)
  • Table 79. France Pharmaceutical Contract Research and Manufacturing, by Phase USD Million (2015-2020)
  • Table 80. France Pharmaceutical Contract Research and Manufacturing, by Enterprise Size USD Million (2015-2020)
  • Table 81. France Pharmaceutical Contract Research and Manufacturing, by Product Type USD Million (2015-2020)
  • Table 82. Italy Pharmaceutical Contract Research and Manufacturing, by Services USD Million (2015-2020)
  • Table 83. Italy Pharmaceutical Contract Research and Manufacturing, by Phase USD Million (2015-2020)
  • Table 84. Italy Pharmaceutical Contract Research and Manufacturing, by Enterprise Size USD Million (2015-2020)
  • Table 85. Italy Pharmaceutical Contract Research and Manufacturing, by Product Type USD Million (2015-2020)
  • Table 86. United Kingdom Pharmaceutical Contract Research and Manufacturing, by Services USD Million (2015-2020)
  • Table 87. United Kingdom Pharmaceutical Contract Research and Manufacturing, by Phase USD Million (2015-2020)
  • Table 88. United Kingdom Pharmaceutical Contract Research and Manufacturing, by Enterprise Size USD Million (2015-2020)
  • Table 89. United Kingdom Pharmaceutical Contract Research and Manufacturing, by Product Type USD Million (2015-2020)
  • Table 90. Netherlands Pharmaceutical Contract Research and Manufacturing, by Services USD Million (2015-2020)
  • Table 91. Netherlands Pharmaceutical Contract Research and Manufacturing, by Phase USD Million (2015-2020)
  • Table 92. Netherlands Pharmaceutical Contract Research and Manufacturing, by Enterprise Size USD Million (2015-2020)
  • Table 93. Netherlands Pharmaceutical Contract Research and Manufacturing, by Product Type USD Million (2015-2020)
  • Table 94. Rest of Europe Pharmaceutical Contract Research and Manufacturing, by Services USD Million (2015-2020)
  • Table 95. Rest of Europe Pharmaceutical Contract Research and Manufacturing, by Phase USD Million (2015-2020)
  • Table 96. Rest of Europe Pharmaceutical Contract Research and Manufacturing, by Enterprise Size USD Million (2015-2020)
  • Table 97. Rest of Europe Pharmaceutical Contract Research and Manufacturing, by Product Type USD Million (2015-2020)
  • Table 98. MEA Pharmaceutical Contract Research and Manufacturing, by Country USD Million (2015-2020)
  • Table 99. MEA Pharmaceutical Contract Research and Manufacturing, by Services USD Million (2015-2020)
  • Table 100. MEA Pharmaceutical Contract Research and Manufacturing, by Phase USD Million (2015-2020)
  • Table 101. MEA Pharmaceutical Contract Research and Manufacturing, by Enterprise Size USD Million (2015-2020)
  • Table 102. MEA Pharmaceutical Contract Research and Manufacturing, by Product Type USD Million (2015-2020)
  • Table 103. Middle East Pharmaceutical Contract Research and Manufacturing, by Services USD Million (2015-2020)
  • Table 104. Middle East Pharmaceutical Contract Research and Manufacturing, by Phase USD Million (2015-2020)
  • Table 105. Middle East Pharmaceutical Contract Research and Manufacturing, by Enterprise Size USD Million (2015-2020)
  • Table 106. Middle East Pharmaceutical Contract Research and Manufacturing, by Product Type USD Million (2015-2020)
  • Table 107. Africa Pharmaceutical Contract Research and Manufacturing, by Services USD Million (2015-2020)
  • Table 108. Africa Pharmaceutical Contract Research and Manufacturing, by Phase USD Million (2015-2020)
  • Table 109. Africa Pharmaceutical Contract Research and Manufacturing, by Enterprise Size USD Million (2015-2020)
  • Table 110. Africa Pharmaceutical Contract Research and Manufacturing, by Product Type USD Million (2015-2020)
  • Table 111. North America Pharmaceutical Contract Research and Manufacturing, by Country USD Million (2015-2020)
  • Table 112. North America Pharmaceutical Contract Research and Manufacturing, by Services USD Million (2015-2020)
  • Table 113. North America Pharmaceutical Contract Research and Manufacturing, by Phase USD Million (2015-2020)
  • Table 114. North America Pharmaceutical Contract Research and Manufacturing, by Enterprise Size USD Million (2015-2020)
  • Table 115. North America Pharmaceutical Contract Research and Manufacturing, by Product Type USD Million (2015-2020)
  • Table 116. United States Pharmaceutical Contract Research and Manufacturing, by Services USD Million (2015-2020)
  • Table 117. United States Pharmaceutical Contract Research and Manufacturing, by Phase USD Million (2015-2020)
  • Table 118. United States Pharmaceutical Contract Research and Manufacturing, by Enterprise Size USD Million (2015-2020)
  • Table 119. United States Pharmaceutical Contract Research and Manufacturing, by Product Type USD Million (2015-2020)
  • Table 120. Canada Pharmaceutical Contract Research and Manufacturing, by Services USD Million (2015-2020)
  • Table 121. Canada Pharmaceutical Contract Research and Manufacturing, by Phase USD Million (2015-2020)
  • Table 122. Canada Pharmaceutical Contract Research and Manufacturing, by Enterprise Size USD Million (2015-2020)
  • Table 123. Canada Pharmaceutical Contract Research and Manufacturing, by Product Type USD Million (2015-2020)
  • Table 124. Mexico Pharmaceutical Contract Research and Manufacturing, by Services USD Million (2015-2020)
  • Table 125. Mexico Pharmaceutical Contract Research and Manufacturing, by Phase USD Million (2015-2020)
  • Table 126. Mexico Pharmaceutical Contract Research and Manufacturing, by Enterprise Size USD Million (2015-2020)
  • Table 127. Mexico Pharmaceutical Contract Research and Manufacturing, by Product Type USD Million (2015-2020)
  • Table 128. Company Basic Information, Sales Area and Its Competitors
  • Table 129. Company Basic Information, Sales Area and Its Competitors
  • Table 130. Company Basic Information, Sales Area and Its Competitors
  • Table 131. Company Basic Information, Sales Area and Its Competitors
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Company Basic Information, Sales Area and Its Competitors
  • Table 138. Company Basic Information, Sales Area and Its Competitors
  • Table 139. Pharmaceutical Contract Research and Manufacturing: by Services(USD Million)
  • Table 140. Pharmaceutical Contract Research and Manufacturing Synthetic Route Design & Scouting Services , by Region USD Million (2021-2026)
  • Table 141. Pharmaceutical Contract Research and Manufacturing High-end Chemical Process Development , by Region USD Million (2021-2026)
  • Table 142. Pharmaceutical Contract Research and Manufacturing Advanced Drug Delivery Formulations Packaging , by Region USD Million (2021-2026)
  • Table 143. Pharmaceutical Contract Research and Manufacturing Finished Dose Formulations , by Region USD Million (2021-2026)
  • Table 144. Pharmaceutical Contract Research and Manufacturing Process Validation followed by Commercial Manufacturing , by Region USD Million (2021-2026)
  • Table 145. Pharmaceutical Contract Research and Manufacturing Others , by Region USD Million (2021-2026)
  • Table 146. Pharmaceutical Contract Research and Manufacturing: by Phase(USD Million)
  • Table 147. Pharmaceutical Contract Research and Manufacturing Phase I , by Region USD Million (2021-2026)
  • Table 148. Pharmaceutical Contract Research and Manufacturing Phase IIa , by Region USD Million (2021-2026)
  • Table 149. Pharmaceutical Contract Research and Manufacturing Phase II-III , by Region USD Million (2021-2026)
  • Table 150. Pharmaceutical Contract Research and Manufacturing Phase IIIb-IV , by Region USD Million (2021-2026)
  • Table 151. Pharmaceutical Contract Research and Manufacturing: by Enterprise Size(USD Million)
  • Table 152. Pharmaceutical Contract Research and Manufacturing Large Enterprise , by Region USD Million (2021-2026)
  • Table 153. Pharmaceutical Contract Research and Manufacturing Small and Medium Enterprise (SME) , by Region USD Million (2021-2026)
  • Table 154. Pharmaceutical Contract Research and Manufacturing: by Product Type(USD Million)
  • Table 155. Pharmaceutical Contract Research and Manufacturing Oncology , by Region USD Million (2021-2026)
  • Table 156. Pharmaceutical Contract Research and Manufacturing Vaccines , by Region USD Million (2021-2026)
  • Table 157. Pharmaceutical Contract Research and Manufacturing Inflammation & Immunology , by Region USD Million (2021-2026)
  • Table 158. Pharmaceutical Contract Research and Manufacturing Cardiology , by Region USD Million (2021-2026)
  • Table 159. Pharmaceutical Contract Research and Manufacturing Neuroscience , by Region USD Million (2021-2026)
  • Table 160. Pharmaceutical Contract Research and Manufacturing Others , by Region USD Million (2021-2026)
  • Table 161. South America Pharmaceutical Contract Research and Manufacturing, by Country USD Million (2021-2026)
  • Table 162. South America Pharmaceutical Contract Research and Manufacturing, by Services USD Million (2021-2026)
  • Table 163. South America Pharmaceutical Contract Research and Manufacturing, by Phase USD Million (2021-2026)
  • Table 164. South America Pharmaceutical Contract Research and Manufacturing, by Enterprise Size USD Million (2021-2026)
  • Table 165. South America Pharmaceutical Contract Research and Manufacturing, by Product Type USD Million (2021-2026)
  • Table 166. Brazil Pharmaceutical Contract Research and Manufacturing, by Services USD Million (2021-2026)
  • Table 167. Brazil Pharmaceutical Contract Research and Manufacturing, by Phase USD Million (2021-2026)
  • Table 168. Brazil Pharmaceutical Contract Research and Manufacturing, by Enterprise Size USD Million (2021-2026)
  • Table 169. Brazil Pharmaceutical Contract Research and Manufacturing, by Product Type USD Million (2021-2026)
  • Table 170. Argentina Pharmaceutical Contract Research and Manufacturing, by Services USD Million (2021-2026)
  • Table 171. Argentina Pharmaceutical Contract Research and Manufacturing, by Phase USD Million (2021-2026)
  • Table 172. Argentina Pharmaceutical Contract Research and Manufacturing, by Enterprise Size USD Million (2021-2026)
  • Table 173. Argentina Pharmaceutical Contract Research and Manufacturing, by Product Type USD Million (2021-2026)
  • Table 174. Rest of South America Pharmaceutical Contract Research and Manufacturing, by Services USD Million (2021-2026)
  • Table 175. Rest of South America Pharmaceutical Contract Research and Manufacturing, by Phase USD Million (2021-2026)
  • Table 176. Rest of South America Pharmaceutical Contract Research and Manufacturing, by Enterprise Size USD Million (2021-2026)
  • Table 177. Rest of South America Pharmaceutical Contract Research and Manufacturing, by Product Type USD Million (2021-2026)
  • Table 178. Asia Pacific Pharmaceutical Contract Research and Manufacturing, by Country USD Million (2021-2026)
  • Table 179. Asia Pacific Pharmaceutical Contract Research and Manufacturing, by Services USD Million (2021-2026)
  • Table 180. Asia Pacific Pharmaceutical Contract Research and Manufacturing, by Phase USD Million (2021-2026)
  • Table 181. Asia Pacific Pharmaceutical Contract Research and Manufacturing, by Enterprise Size USD Million (2021-2026)
  • Table 182. Asia Pacific Pharmaceutical Contract Research and Manufacturing, by Product Type USD Million (2021-2026)
  • Table 183. China Pharmaceutical Contract Research and Manufacturing, by Services USD Million (2021-2026)
  • Table 184. China Pharmaceutical Contract Research and Manufacturing, by Phase USD Million (2021-2026)
  • Table 185. China Pharmaceutical Contract Research and Manufacturing, by Enterprise Size USD Million (2021-2026)
  • Table 186. China Pharmaceutical Contract Research and Manufacturing, by Product Type USD Million (2021-2026)
  • Table 187. Japan Pharmaceutical Contract Research and Manufacturing, by Services USD Million (2021-2026)
  • Table 188. Japan Pharmaceutical Contract Research and Manufacturing, by Phase USD Million (2021-2026)
  • Table 189. Japan Pharmaceutical Contract Research and Manufacturing, by Enterprise Size USD Million (2021-2026)
  • Table 190. Japan Pharmaceutical Contract Research and Manufacturing, by Product Type USD Million (2021-2026)
  • Table 191. India Pharmaceutical Contract Research and Manufacturing, by Services USD Million (2021-2026)
  • Table 192. India Pharmaceutical Contract Research and Manufacturing, by Phase USD Million (2021-2026)
  • Table 193. India Pharmaceutical Contract Research and Manufacturing, by Enterprise Size USD Million (2021-2026)
  • Table 194. India Pharmaceutical Contract Research and Manufacturing, by Product Type USD Million (2021-2026)
  • Table 195. South Korea Pharmaceutical Contract Research and Manufacturing, by Services USD Million (2021-2026)
  • Table 196. South Korea Pharmaceutical Contract Research and Manufacturing, by Phase USD Million (2021-2026)
  • Table 197. South Korea Pharmaceutical Contract Research and Manufacturing, by Enterprise Size USD Million (2021-2026)
  • Table 198. South Korea Pharmaceutical Contract Research and Manufacturing, by Product Type USD Million (2021-2026)
  • Table 199. Australia Pharmaceutical Contract Research and Manufacturing, by Services USD Million (2021-2026)
  • Table 200. Australia Pharmaceutical Contract Research and Manufacturing, by Phase USD Million (2021-2026)
  • Table 201. Australia Pharmaceutical Contract Research and Manufacturing, by Enterprise Size USD Million (2021-2026)
  • Table 202. Australia Pharmaceutical Contract Research and Manufacturing, by Product Type USD Million (2021-2026)
  • Table 203. Rest of Asia-Pacific Pharmaceutical Contract Research and Manufacturing, by Services USD Million (2021-2026)
  • Table 204. Rest of Asia-Pacific Pharmaceutical Contract Research and Manufacturing, by Phase USD Million (2021-2026)
  • Table 205. Rest of Asia-Pacific Pharmaceutical Contract Research and Manufacturing, by Enterprise Size USD Million (2021-2026)
  • Table 206. Rest of Asia-Pacific Pharmaceutical Contract Research and Manufacturing, by Product Type USD Million (2021-2026)
  • Table 207. Europe Pharmaceutical Contract Research and Manufacturing, by Country USD Million (2021-2026)
  • Table 208. Europe Pharmaceutical Contract Research and Manufacturing, by Services USD Million (2021-2026)
  • Table 209. Europe Pharmaceutical Contract Research and Manufacturing, by Phase USD Million (2021-2026)
  • Table 210. Europe Pharmaceutical Contract Research and Manufacturing, by Enterprise Size USD Million (2021-2026)
  • Table 211. Europe Pharmaceutical Contract Research and Manufacturing, by Product Type USD Million (2021-2026)
  • Table 212. Germany Pharmaceutical Contract Research and Manufacturing, by Services USD Million (2021-2026)
  • Table 213. Germany Pharmaceutical Contract Research and Manufacturing, by Phase USD Million (2021-2026)
  • Table 214. Germany Pharmaceutical Contract Research and Manufacturing, by Enterprise Size USD Million (2021-2026)
  • Table 215. Germany Pharmaceutical Contract Research and Manufacturing, by Product Type USD Million (2021-2026)
  • Table 216. France Pharmaceutical Contract Research and Manufacturing, by Services USD Million (2021-2026)
  • Table 217. France Pharmaceutical Contract Research and Manufacturing, by Phase USD Million (2021-2026)
  • Table 218. France Pharmaceutical Contract Research and Manufacturing, by Enterprise Size USD Million (2021-2026)
  • Table 219. France Pharmaceutical Contract Research and Manufacturing, by Product Type USD Million (2021-2026)
  • Table 220. Italy Pharmaceutical Contract Research and Manufacturing, by Services USD Million (2021-2026)
  • Table 221. Italy Pharmaceutical Contract Research and Manufacturing, by Phase USD Million (2021-2026)
  • Table 222. Italy Pharmaceutical Contract Research and Manufacturing, by Enterprise Size USD Million (2021-2026)
  • Table 223. Italy Pharmaceutical Contract Research and Manufacturing, by Product Type USD Million (2021-2026)
  • Table 224. United Kingdom Pharmaceutical Contract Research and Manufacturing, by Services USD Million (2021-2026)
  • Table 225. United Kingdom Pharmaceutical Contract Research and Manufacturing, by Phase USD Million (2021-2026)
  • Table 226. United Kingdom Pharmaceutical Contract Research and Manufacturing, by Enterprise Size USD Million (2021-2026)
  • Table 227. United Kingdom Pharmaceutical Contract Research and Manufacturing, by Product Type USD Million (2021-2026)
  • Table 228. Netherlands Pharmaceutical Contract Research and Manufacturing, by Services USD Million (2021-2026)
  • Table 229. Netherlands Pharmaceutical Contract Research and Manufacturing, by Phase USD Million (2021-2026)
  • Table 230. Netherlands Pharmaceutical Contract Research and Manufacturing, by Enterprise Size USD Million (2021-2026)
  • Table 231. Netherlands Pharmaceutical Contract Research and Manufacturing, by Product Type USD Million (2021-2026)
  • Table 232. Rest of Europe Pharmaceutical Contract Research and Manufacturing, by Services USD Million (2021-2026)
  • Table 233. Rest of Europe Pharmaceutical Contract Research and Manufacturing, by Phase USD Million (2021-2026)
  • Table 234. Rest of Europe Pharmaceutical Contract Research and Manufacturing, by Enterprise Size USD Million (2021-2026)
  • Table 235. Rest of Europe Pharmaceutical Contract Research and Manufacturing, by Product Type USD Million (2021-2026)
  • Table 236. MEA Pharmaceutical Contract Research and Manufacturing, by Country USD Million (2021-2026)
  • Table 237. MEA Pharmaceutical Contract Research and Manufacturing, by Services USD Million (2021-2026)
  • Table 238. MEA Pharmaceutical Contract Research and Manufacturing, by Phase USD Million (2021-2026)
  • Table 239. MEA Pharmaceutical Contract Research and Manufacturing, by Enterprise Size USD Million (2021-2026)
  • Table 240. MEA Pharmaceutical Contract Research and Manufacturing, by Product Type USD Million (2021-2026)
  • Table 241. Middle East Pharmaceutical Contract Research and Manufacturing, by Services USD Million (2021-2026)
  • Table 242. Middle East Pharmaceutical Contract Research and Manufacturing, by Phase USD Million (2021-2026)
  • Table 243. Middle East Pharmaceutical Contract Research and Manufacturing, by Enterprise Size USD Million (2021-2026)
  • Table 244. Middle East Pharmaceutical Contract Research and Manufacturing, by Product Type USD Million (2021-2026)
  • Table 245. Africa Pharmaceutical Contract Research and Manufacturing, by Services USD Million (2021-2026)
  • Table 246. Africa Pharmaceutical Contract Research and Manufacturing, by Phase USD Million (2021-2026)
  • Table 247. Africa Pharmaceutical Contract Research and Manufacturing, by Enterprise Size USD Million (2021-2026)
  • Table 248. Africa Pharmaceutical Contract Research and Manufacturing, by Product Type USD Million (2021-2026)
  • Table 249. North America Pharmaceutical Contract Research and Manufacturing, by Country USD Million (2021-2026)
  • Table 250. North America Pharmaceutical Contract Research and Manufacturing, by Services USD Million (2021-2026)
  • Table 251. North America Pharmaceutical Contract Research and Manufacturing, by Phase USD Million (2021-2026)
  • Table 252. North America Pharmaceutical Contract Research and Manufacturing, by Enterprise Size USD Million (2021-2026)
  • Table 253. North America Pharmaceutical Contract Research and Manufacturing, by Product Type USD Million (2021-2026)
  • Table 254. United States Pharmaceutical Contract Research and Manufacturing, by Services USD Million (2021-2026)
  • Table 255. United States Pharmaceutical Contract Research and Manufacturing, by Phase USD Million (2021-2026)
  • Table 256. United States Pharmaceutical Contract Research and Manufacturing, by Enterprise Size USD Million (2021-2026)
  • Table 257. United States Pharmaceutical Contract Research and Manufacturing, by Product Type USD Million (2021-2026)
  • Table 258. Canada Pharmaceutical Contract Research and Manufacturing, by Services USD Million (2021-2026)
  • Table 259. Canada Pharmaceutical Contract Research and Manufacturing, by Phase USD Million (2021-2026)
  • Table 260. Canada Pharmaceutical Contract Research and Manufacturing, by Enterprise Size USD Million (2021-2026)
  • Table 261. Canada Pharmaceutical Contract Research and Manufacturing, by Product Type USD Million (2021-2026)
  • Table 262. Mexico Pharmaceutical Contract Research and Manufacturing, by Services USD Million (2021-2026)
  • Table 263. Mexico Pharmaceutical Contract Research and Manufacturing, by Phase USD Million (2021-2026)
  • Table 264. Mexico Pharmaceutical Contract Research and Manufacturing, by Enterprise Size USD Million (2021-2026)
  • Table 265. Mexico Pharmaceutical Contract Research and Manufacturing, by Product Type USD Million (2021-2026)
  • Table 266. Research Programs/Design for This Report
  • Table 267. Key Data Information from Secondary Sources
  • Table 268. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Pharmaceutical Contract Research and Manufacturing: by Services USD Million (2015-2020)
  • Figure 5. Global Pharmaceutical Contract Research and Manufacturing: by Phase USD Million (2015-2020)
  • Figure 6. Global Pharmaceutical Contract Research and Manufacturing: by Enterprise Size USD Million (2015-2020)
  • Figure 7. Global Pharmaceutical Contract Research and Manufacturing: by Product Type USD Million (2015-2020)
  • Figure 8. South America Pharmaceutical Contract Research and Manufacturing Share (%), by Country
  • Figure 9. Asia Pacific Pharmaceutical Contract Research and Manufacturing Share (%), by Country
  • Figure 10. Europe Pharmaceutical Contract Research and Manufacturing Share (%), by Country
  • Figure 11. MEA Pharmaceutical Contract Research and Manufacturing Share (%), by Country
  • Figure 12. North America Pharmaceutical Contract Research and Manufacturing Share (%), by Country
  • Figure 13. Global Pharmaceutical Contract Research and Manufacturing share by Players 2020 (%)
  • Figure 14. Global Pharmaceutical Contract Research and Manufacturing share by Players (Top 3) 2020(%)
  • Figure 15. Global Pharmaceutical Contract Research and Manufacturing share by Players (Top 5) 2020(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Patheon (Thermo Fisher Scientific) (United States) Revenue, Net Income and Gross profit
  • Figure 18. Patheon (Thermo Fisher Scientific) (United States) Revenue: by Geography 2020
  • Figure 19. Boehringer Ingelheim (Germany) Revenue, Net Income and Gross profit
  • Figure 20. Boehringer Ingelheim (Germany) Revenue: by Geography 2020
  • Figure 21. Labcorp (United States) Revenue, Net Income and Gross profit
  • Figure 22. Labcorp (United States) Revenue: by Geography 2020
  • Figure 23. IQVIA (United States) Revenue, Net Income and Gross profit
  • Figure 24. IQVIA (United States) Revenue: by Geography 2020
  • Figure 25. PPD, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 26. PPD, Inc. (United States) Revenue: by Geography 2020
  • Figure 27. Sun Pharmaceutical Industries Ltd. (India) Revenue, Net Income and Gross profit
  • Figure 28. Sun Pharmaceutical Industries Ltd. (India) Revenue: by Geography 2020
  • Figure 29. Medpace (United States) Revenue, Net Income and Gross profit
  • Figure 30. Medpace (United States) Revenue: by Geography 2020
  • Figure 31. Syngene International Limited (India) Revenue, Net Income and Gross profit
  • Figure 32. Syngene International Limited (India) Revenue: by Geography 2020
  • Figure 33. WuXi AppTec (China) Revenue, Net Income and Gross profit
  • Figure 34. WuXi AppTec (China) Revenue: by Geography 2020
  • Figure 35. ICON plc (Ireland) Revenue, Net Income and Gross profit
  • Figure 36. ICON plc (Ireland) Revenue: by Geography 2020
  • Figure 37. Lonza Group AG (Switzerland) Revenue, Net Income and Gross profit
  • Figure 38. Lonza Group AG (Switzerland) Revenue: by Geography 2020
  • Figure 39. Global Pharmaceutical Contract Research and Manufacturing: by Services USD Million (2021-2026)
  • Figure 40. Global Pharmaceutical Contract Research and Manufacturing: by Phase USD Million (2021-2026)
  • Figure 41. Global Pharmaceutical Contract Research and Manufacturing: by Enterprise Size USD Million (2021-2026)
  • Figure 42. Global Pharmaceutical Contract Research and Manufacturing: by Product Type USD Million (2021-2026)
  • Figure 43. South America Pharmaceutical Contract Research and Manufacturing Share (%), by Country
  • Figure 44. Asia Pacific Pharmaceutical Contract Research and Manufacturing Share (%), by Country
  • Figure 45. Europe Pharmaceutical Contract Research and Manufacturing Share (%), by Country
  • Figure 46. MEA Pharmaceutical Contract Research and Manufacturing Share (%), by Country
  • Figure 47. North America Pharmaceutical Contract Research and Manufacturing Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Patheon (Thermo Fisher Scientific) (United States)
  • Boehringer Ingelheim (Germany)
  • Labcorp (United States)
  • IQVIA (United States)
  • PPD, Inc. (United States)
  • Sun Pharmaceutical Industries Ltd. (India)
  • Medpace (United States)
  • Syngene International Limited (India)
  • WuXi AppTec (China)
  • ICON plc (Ireland)
  • Lonza Group AG (Switzerland)
Additional players considered in the study are as follows:
Charles River Laboratories (United States) , Parexel (United States) ,
Select User Access Type

Key Highlights of Report


Dec 2021 229 Pages 56 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Pharmaceutical Contract Research and Manufacturing Market Quantitative research analysis
Global Pharmaceutical Contract Research and Manufacturing Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The Pharmaceutical Contract Research and Manufacturing market is expected to see a CAGR of % during projected year 2020 to 2026.
Top performing companies in the Global Pharmaceutical Contract Research and Manufacturing market are Patheon (Thermo Fisher Scientific) (United States), Boehringer Ingelheim (Germany), Labcorp (United States), IQVIA (United States), PPD, Inc. (United States), Sun Pharmaceutical Industries Ltd. (India), Medpace (United States), Syngene International Limited (India), WuXi AppTec (China), ICON plc (Ireland) and Lonza Group AG (Switzerland), to name a few.
"Rapid Development of AI and Electronic Platforms in CRM " is seen as one of major influencing trends for Pharmaceutical Contract Research and Manufacturing Market during projected period 2020-2026.

Know More About Global Pharmaceutical Contract Research and Manufacturing Market Report?

Have a Query? Click Here

Other Related Reports

Nucleic Vaccine Comprehensive Study by Application (Hospital, Clinic, Others), Disease (AIDS, Hepatitis B and C, Influenza, Warts) Players and Region - Global Market Outlook to 2026
$ 3500
Cognitive Decline Comprehensive Study by Treatment (Symptomatic Therapies, Preventive Therapies), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Drug Stores, Mail Order Pharmacies, Onl...
$ 3750
Cyromazine Drug Comprehensive Study by Application (Insecticide, Insect Growth Regulator, Veterinary Substance), End User (Animal Health Care, Agriculture Industry, Other), Side effect (Irritate The ...
$ 3350
Breast Cyst Treatment Comprehensive Study by Treatment (Surgeries, Radiotherapy, Fine Needle Aspiration, Hormonal Therapy), End-user (Hospitals, Clinics, Ambulatory Surgical Centers, Other), Size (M...
$ 3350
Genetic Obesity Drugs Comprehensive Study by Type (Monogenic, Syndromic), Category (Class 1: BMI - 30 to < 35, Class 2: BMI - 35 to < 40, Class 3: BMI - > 40), Drug (Bupropion-naltrexone, Liragluti...
$ 3750
Buprenorphine Comprehensive Study by Application (Hospital, Clinic, Other), Side Effect (Sedation, Dizziness, Headache, Low blood pressure (hypotension), Slow breathing), Distribution Channel (Hospi...
$ 3450